MMMarc C. Moore

Marc C. Moore

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marc C. Moore has a total of 13 co-authors. Here are the top co-authors by number of shared publications:

  • Peter S. McFetridge

    J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, USA

    6 shared publications
  • Aurore Van de Walle

    Laboratoire Physique des Cellules et Cancer, PCC, CNRS UMR168, Institut Curie, Sorbonne Université, PSL Research University, 75005 Paris, France

    2 shared publications
  • Amanda H. Walker

    1 shared publication
  • Ashley A. Weiner

    Department of Biomedical Engineering, Vanderbilt University, 5824 Stevenson Center, Nashville, TN 37232, USA

    1 shared publication
  • Blanka Sharma

    J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, JG-56 Biomedical Sciences Building, P.O. Box 116131, Gainesville, FL, 32611-6131, USA

    1 shared publication
  • Cassandra Juran

    NASA Ames Research Center Space Bioscience BLDG 236 MS: 236‐7 Moffett Field CA 94035 USA

    1 shared publication

Latest Publications

  • Sequential adaptation of perfusion and transport conditions significantly improves vascular construct recellularization and biomechanics

    by Aurore B. Van de Walle, Marc C. Moore, Peter S. McFetridge

    Recellularization of ex vivo‐derived scaffolds remains a significant hurdle primarily due to the scaffolds subcellular pore size that restricts initial cell seeding to the scaffolds periphery and inhibits migration over time. With the aim to improve cell migration, repopulation, and graft mechanics, the effects of a 4‐step culture approach were assessed. Using an ex vivo‐derived vein as a model scaffold, human smooth muscle cells were first seeded onto its ablumen (step 1 – 3h) and an aggressive 0‐100 % nutrient gradient (lumenal flow under hypotensive pressure) was created to initiate cell migration across the scaffold (step 2 – days 0 to 19). The effects of a prolonged aggressive nutrient gradient created by this single lumenal flow was then compared to a dual flow (lumenal and ablumenal) in step 3 (days 20 to 30). Analyses showed that a single lumenal flow maintained for 30 days resulted in a higher proportion of cells migrating across the scaffold toward the vessel lumen (nutrient source), with improved distribution. In step 4 (days 31 to 45), the transition from hypotensive pressure (12/8 mmHg) to normotensive (arterial‐like) pressure (120/80 mmHg) was assessed. It demonstrated that recellularized scaffolds exposed to arterial pressures have increased glycosaminoglycan deposition, physiological modulus, and Young's modulus. By using this step‐wise conditioning, the challenging recellularization of a vein‐based scaffold and its positive remodeling toward arterial biomechanics were obtained.


  • Human Perinatal‐Derived Biomaterials

    by Marc C. Moore, Aurore Van De Walle, Jerry Chang, Cassandra Juran, Peter S. McFetridge

    Human perinatal tissues have been used for over a century as allogeneic biomaterials. Due to their advantageous properties including angiogenecity, anti‐inflammation, anti‐microbial, and immune privilege, these tissues are being utilized for novel applications across wide‐ranging medical disciplines. Given continued clinical success, increased adoption of perinatal tissues as a disruptive technology platform has allowed for significant penetration into the multi‐billion dollar biologics market. Here, we review current progress and future applications of perinatal biomaterials, as well as associated regulatory issues.


  • Controlled release of a heterogeneous human placental matrix from PLGA microparticles to modulate angiogenesis

    by Sarah Tonello, Marc C. Moore, Blanka Sharma, Jon Dobson, Peter S. McFetridge

    A significant hurdle limiting musculoskeletal tissue regeneration is the inability to develop effective vascular networks to support cellular development within engineered constructs. Due to the inherent complexity of angiogenesis, where multiple biochemical pathways induce and control vessel formation, our laboratory has taken an alternate approach using a matrix material containing angiogenic and osteogenic proteins derived from human placental tissues. Single bolus administrations of the human placental matrix (hPM) have been shown to initiate angiogenesis but vascular networks deteriorated over time. Controlled/sustained delivery was therefore hypothesized to stabilize and extend network formation. To test this hypothesis, hPM was encapsulated in degradable poly(lactic-co-glycolic acid) (PLGA) microparticles to extend the release period. Microparticle preparation including loading, size, encapsulation efficiency, and release profile was optimized for hPM. The angiogenic cellular response to the hPM/PLGA-loaded microparticles was assessed in 3D alginate hydrogel matrices seeded with primary human endothelial cells. Results show an average microparticle diameter of 91.82 ± 2.92 μm, with an encapsulation efficiency of 75 %, and a release profile extending over 30 days. Three-dimensional angiogenic assays with hPM-loaded PLGA microparticles showed initial stimulation of angiogenic tubules after 14 days and further defined network formations after 21 days of culture. Although additional optimization is necessary, these studies confirm the effectiveness of a novel controlled multi-protein release approach to induce and maintain capillary networks within alginate tissue scaffolds.


  • Directed Oxygen Gradients Initiate a Robust Early Remodeling Response in Engineered Vascular Grafts

    by Marc Moore, Ruben Moore, Peter S. McFetridge

    Whereas functionally different, both organogenesis and wound-healing processes create zones or regions of hypoxia that persist until capillary networks are formed to facilitate oxygen and nutrient delivery. Similarly, regenerative processes within in vitro engineered tissues experience the same hypoxic regions, but without the capacity to form functional capillaries resulting in a major limitation in developing full-thickness organs and tissues. Due to the importance of oxygen in wound healing and tissue regeneration, we hypothesize that directed oxygen gradients can be used to modulate cell function and promote more effective tissue regeneration. The effect of controlled oxygen gradients on human smooth muscle cells (SMCs) was assessed using dual chambered perfusion bioreactors to regulate transport conditions occurring in a model vascular construct. SMCs were seeded onto the ablumenal surface of the scaffold and cultured for 21 days under 3 independent gas environments: (1) 21% oxygen, (2) 11% oxygen, or (3) an ablumen to lumen oxygen gradient from 11% to 21%. When compared to 21% oxygen and 11% oxygen conditions, the directed 11%–21% oxygen gradient resulted in a raised metabolic activity and significantly improved cell migration. After 21 days from seeding, cells were shown to migrate entirely across the scaffold to the vessel lumen (>450 μm). Concomitant with a more uniform cell dispersion, scaffold mechanics were significantly enhanced with increased stiffness and tensile strength. Native oxygen gradients are known to play a pivotal role during organ development; these results show that directed oxygen gradients within in vitro systems can be used to facilitate early remodeling leading to significantly enhanced cell migration and scaffold biomechanics.


  • Mass transfer trends occurring in engineered ex vivo tissue scaffolds

    by Marc Moore, Malisa Sarntinoranont, Peter McFetridge


  • Modulation of protein release from photocrosslinked networks by gelatin microparticles

    by Ashley A. Weiner, Marc C. Moore, Amanda H. Walker, V. Prasad Shastri